ClinicalTrialsFinder

Radioiodine-refractory Differentiated Thyroid Cancer Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Poorly Differentiated Thyroid CarcinomaAdvanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid Cancer
Zhejiang Provincial People's Hospital94 enrolled1 locationNCT07068542